Concomitant with the increased availability of 5-FU and FP drugs were increased investigations into mechanisms beyond TS inhibition [11] that are important for the anti-cancer activities of FP drugs, which include the poisoning of DNA topoisomerase 1 (Top1; [12,13]). Here, TOP1 is linked to cancer.